ArticleMolecular therapy. Oncology2026

Oncolytic adenoviruses encoding bispecific T cell engagers or a novel trispecific T cell engager for dual-targeting of c-MET and EGFR.

Martin A Boos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.